Is Biodesix Inc (BDSX) a Winner in the Diagnostics & Research Industry?

Biodesix Inc (BDSX) is around the top of the Diagnostics & Research industry according to InvestorsObserver. BDSX received an overall rating of 65, which means that it scores higher than 65 percent of all stocks. Biodesix Inc also achieved a score of 96 in the Diagnostics & Research industry, putting it above 96 percent of Diagnostics & Research stocks. Diagnostics & Research is ranked 96 out of the 148 industries.

BDSX has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on BDSX!

See Full BDSX Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 65 means the stock is more attractive than 65 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Biodesix Inc Stock Today?

Biodesix Inc (BDSX) stock is trading at $1.45 as of 12:47 PM on Wednesday, Nov 22, a rise of $0.13, or 9.85% from the previous closing price of $1.32. The stock has traded between $1.38 and $1.46 so far today. Volume today is less active than usual. So far 23,426 shares have traded compared to average volume of 41,737 shares. Click Here to get the full Stock Report for Biodesix Inc stock.